Notably, while some studies suggest that GH treatment improves bone mineral density (BMD) in PWS patients [3], others report a gradual decline in the BMD standard deviation score (BMD-SDS) despite long-term GH therapy [4,5]. The gene discussed is GH1; the disease is Prader-Willi syndrome.